Disease overview Chronic lymphocytic leukemia (CLL) is one of the most frequent types of
leukemia. It typically occurs in elderly patients and has a highly variable clinical course …

Abstract Disease Overview Chronic lymphocytic leukemia (CLL) is the commonest leukemia
in western countries. The disease typically occurs in elderly patients and has a highly …

Disease overview Chronic lymphocytic leukemia (CLL) is the commonest leukemia in
western countries. The disease typically occurs in elderly patients and has a highly variable …

Standardized criteria for diagnosis and response assessment are needed to interpret and
compare clinical trials and for approval of new therapeutic agents by regulatory agencies …

Disease overview: Chronic lymphocytic leukemia (CLL) is the commonest leukemia in
western countries. The disease typically occurs in elderly patients and has a highly variable …

Purpose To determine the clinical significance of flow cytometric minimal residual disease
(MRD) quantification in chronic lymphocytic leukemia (CLL) in addition to pretherapeutic risk …

Purpose Fludarabine and cyclophosphamide (FC), which are active in treatment of chronic
lymphocytic leukemia (CLL), are synergistic with the monoclonal antibody rituximab in vitro …

Purpose The efficacy, toxicity, and tolerability of chemoimmunotherapy with the combination
of fludarabine, cyclophosphamide, and rituximab (FCR) were evaluated in previously treated …

Chronic lymphocytic leukaemia is the commonest form of leukaemia in Europe and North
America, and mainly, though not exclusively, affects older individuals. It has a very variable …

The aim of this project was to identify situations where allogeneic stem cell transplantation
(allo-SCT) might be considered as a preferred treatment option for patients with B-cell …